STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

PLXP PLX PHARMA INCORPORATED StockScouter® Report

5

StockScouter® Score

PLX PHARMA INCORPORATED, a micro cap company in the healthcare sector, is expected to slightly outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The 50-day moving average for PLXP is significantly above its 200-day moving average. Positive
  • Short-term relative price momentum exhibits meaningful strength. Postive

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 60% done.
Progress: 80% done.
Low
High

Core Model Grades

C
B
F
B

Previous Ratings

5
4
5